Skip to content

DISCLAIMER: This article is a SPONSORED Press Release and does not constitute Finbold's editorial content. Crypto assets/products involve significant risks. Do not invest unless you are prepared to lose your entire investment. For a full disclaimer, please click here.

Technical Analysis Shows 85% Rally for INJ in August, ALGT Could Go Even Higher After Listing

Press Releases

After the BTC price has raced near the $60k threshold, the market takes a promising turn toward gains. Investors are shifting focus from conventional crypto assets to industry-relevant altcoins, notably AI cryptos. The sentiment shift is evidenced by the 3.3% rise in the market value of the AI crypto sector. 

Injective (INJ) has emerged as a promising choice for investors due to its increased adoption and ongoing developments, setting the stage for notable price gains. Amid sideways momentum, the developing AI sector is expected to substantially contribute to the success of Injective (INJ) by August 2024. 

Injective (INJ) Targets The $37 Support – Price Prediction

The BTC price trajectory is creating a wave of optimism around the broader altcoin sector, especially AI cryptos. Injective (INJ) is a prominent crypto, reaching a bullish zone after a brief consolidation phase. The INJ token is flaring up, indicated by a rising transactional volume as investors turn to its bright prospects. 

Coming to the broader market analysis, a technical analysis of NVIDIA by UBS is set to boost AI altcoins. The predictions include a price target of $150 for the firm, backed by demand for the Blackwell rack-scale systems. Moreover, with the updated EPS guide for 2025, the AI sector is poised to increase revenue and technological advancements, leading Injective (INJ) to upper price levels.  

According to technical indicators, Injective (INJ) follows the BTC price trend with a 3.1% rise on the intraday chart. The Relative Strength Index (RSI) lies below 50, indicating selling pressures for a short period as the value continues to rise. Simple and exponential moving averages give a strong buy signal as the token can fly to the previous threshold at $37 within the next few weeks, indicating an 85% value appreciation for Injective (INJ). 

Algotech Gears Up To Show Strength Amid $9 Million Presale

Algotech (ALGT) aims to advance trading dynamics with its algorithmic platform backed by artificial intelligence and machine learning. With over $9.4 million raised in the bonus round of the public presale, Algotech makes strides by granting access to powerful trading tools to large traders for enhancing and streamlining the trading experience. 

With algorithmic trading strategies and cutting-edge risk management tools, Algotech offers diverse mechanisms for deploying effective approaches to different market conditions for higher returns and minimized risks. Committing to the community-centric approach, Algotech ensures transparency and security in all transactions with governance rights granted to holders. 

With exciting features and real-time market analytics, users can leverage the decentralized marketplace of Algotech to manage and optimize investments effectively with up-to-the-minute information. The deflationary ERC-20 token standard also sets it apart from other cryptos combined with its industry-relevant features. 

Bitmart Announces Listing of Best DeFi Altcoin – Algotech (ALGT)

The bullish momentum of the Algotech presale rally advances toward the most awaited listing of the ALGT tokens. After the confirmation of Bitmart exchange to list Algotech, investors flock to fill bags with the tokens at the low entry points. The pre-launch announcement by large-scale exchanges can be pivotal in raising the demand for Algotech in a competitive market. 

Algotech’s AI platform is the center of attention after selling 92% of ALGT tokens. The presale is set to enter the next stage with the price jump to $0.15 from $0.08. This is a once-in-a-lifetime chance to avail the low-entry point of ALGT tokens and enjoy gains much higher than Injective (INJ) in the upcoming months. 

Learn more:

Visit Algotech Presale

Join The Algotech Community

Disclaimer

This post is sponsored. Finbold neither endorses nor takes responsibility for the accuracy, quality, advertising, products, or other materials on this page. Readers are strongly encouraged to perform their own research before making any decisions regarding the company. Finbold will not be held accountable, either directly or indirectly, for any harm or loss that may stem from or be linked to the usage or reliance on any information, goods, or services mentioned on the page. If you encounter any issues, kindly report them to [email protected].

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.